Building Medical Supply Chain Resilience through a U.S. Manufacturing Reserve and Digital Stockpile
Summary
To prevent another medical supply chain breakdown like the one experienced during the COVID-19 pandemic, the Federal Government must create an emergency response plan to activate domestic, local medical supply manufacturing. A national network of small-to-mid-size manufacturers and prototyping labs — a U.S. Prototyping and Manufacturing Reserve — should be formalized and incentivized to act as first responders for emergency innovation and medical supply manufacturing needs.
To properly equip the Reserve, the Federal Government should build a comprehensive library of open source medical and emergency supply “blueprints” — a U.S. Digital Stockpile — that consists of manufacturing requirements to enable distributed local emergency production. Combined, these new national security resources will facilitate rapid local response to both regional disasters and international supply chain disruptions.
AI is transforming how children learn and live, and policymakers, industry, and educators owe it to the next generation to set in place a responsible policy that embraces this new technology while at the same time ensuring all children’s well-being, privacy, and safety is respected.
A peer support option should be integrated into the 988 Suicide and Crisis Lifeline so that 988 service users can choose to connect with specialists based on a shared lived experience.
Given the rapid pace of AI advancement, a proactive effort triumphs over a reactive one. To protect consumers, workers, and the economy more broadly, it is imperative that the FTC and DOJ adapt their enforcement strategies to meet the complexities of the AI era.
To encourage greater adoption of generic drugs in clinical practice the FDA should implement a dedicated regulatory pathway for non-manufacturers to seek approval of new indications for repurposed generic drugs.